Enhanced dense core granule function and adrenal hypersecretion in a mouse model of Rett syndrome

European Journal of Neuroscience

Volumn 30, Issue 4, 2009, Pages 602-610

  Ladas, Thomas ^a   Chan, Shyue An ^b   Ogier, Michael ^c   Smith, Corey ^b   Katz, David M ^c  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Chromaffin; Exocytosis; Neuroendocrine; Neurosecretion; Sympathetic

Indexed keywords

ADRENALIN; CATECHOLAMINE; METHYL CPG BINDING PROTEIN 2;

ADRENAL GLAND; ADRENAL MEDULLA; ADRENALIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE BRAIN LEVEL; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; CHROMAFFIN GRANULE; CONTROLLED STUDY; ELECTROSTIMULATION; MORPHOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETT SYNDROME; SECRETORY GRANULE; SYMPATHETIC GANGLION;

ADRENAL GLANDS; ANIMALS; CHROMAFFIN GRANULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DISEASE MODELS, ANIMAL; DOPAMINE; ELECTROPHYSIOLOGY; EPINEPHRINE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; MUTATION; NOREPINEPHRINE; RETT SYNDROME; SUPERIOR CERVICAL GANGLION; SYMPATHETIC NERVOUS SYSTEM;

EID: 69249120199     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2009.06858.x     Document Type: Article

References (64)

1. Acampa, M. Guideri, F. (2006) Cardiac disease and Rett syndrome. Arch. Dis. Child., 91, 440 443.
2. Acampa, M., Guideri, F., Hayek, J., Blardi, P., De Lalla, A., Zappella, M. Auteri, A. (2008) Sympathetic overactivity and plasma leptin levels in Rett syndrome. Neurosci. Lett., 432, 69 72.
3. Amatore, C., Bouret, Y., Travis, E.R. Wightman, R.M. (2000) Interplay between membrane dynamics, diffusion and swelling pressure governs individual vesicular exocytotic events during release of adrenaline by chromaffin cells. Biochimie, 82, 481 496.
4. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23, 185 188.
5. Angleson, J.K., Cochilla, A.J., Kilic, G., Nussinovitch, I. Betz, W.J. (1999) Regulation of dense core release from neuroendocrine cells revealed by imaging single exocytic events. Nat. Neurosci., 2, 440 446.
6. Bianchi, A.L., Denavit-Saubie, M. Champagnat, J. (1995) Central control of breathing in mammals: neuronal circuitry, membrane properties, and neurotransmitters. Physiol. Rev., 75, 1 45.
7. Brandt, B.L., Hagiwara, S., Kidokoro, Y. Miyazaki, S. (1976) Action potentials in the rat chromaffin cell and effects of acetylcholine. J. Physiol., 263, 417 439.
8. Bravo, E.L. (1991) Pheochromocytoma: new concepts and future trends. Kidney Int., 40, 544 556.
9. Bravo, E.L. Tagle, R. (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocr. Rev., 24, 539 553.
10. Bretou, M., Anne, C. Darchen, F. (2008) A fast mode of membrane fusion dependent on tight SNARE zippering. J. Neurosci., 28, 8470 8476.
11. Brucke, T., Sofic, E., Killian, W., Rett, A. Riederer, P. (1987) Reduced concentrations and increased metabolism of biogenic amines in a single case of Rett-syndrome: a postmortem brain study. J. Neural Transm., 68, 315 324. (Pubitemid 17008068)
12. Chahrour, M. Zoghbi, H.Y. (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron, 56, 422 437.
13. Chahrour, M., Jung, S.Y., Shaw, C., Zhou, X., Wong, S.T., Qin, J. Zoghbi, H.Y. (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science, 320, 1224 1229.
14. Chan, S.A. Smith, C. (2001) Physiological stimuli evoke two forms of endocytosis in bovine chromaffin cells. J. Physiol., 537, 871 885.
15. Chan, S.A., Polo-Parada, L., Landmesser, L.T. Smith, C. (2005) Adrenal chromaffin cells exhibit impaired granule trafficking in NCAM knockout mice. J. Neurophysiol., 94, 1037 1047.
16. Chen, R.Z., Akbarian, S., Tudor, M. Jaenisch, R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet., 27, 327 331.
17. Chow, R.H., von Ruden, L. Neher, E. (1992) Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells. Nature, 356, 60 63.
18. Elhamdani, A., Brown, M.E., Artalejo, C.R. Palfrey, H.C. (2000) Enhancement of the dense-core vesicle secretory cycle by glucocorticoid differentiation of PC12 cells: characteristics of rapid exocytosis and endocytosis. J. Neurosci., 20, 2495 2503.
19. Fisher, R.J., Pevsner, J. Burgoyne, R.D. (2001) Control of fusion pore dynamics during exocytosis by Munc18. Science, 291, 875 878.
20. Fulop, T. Smith, C. (2006) Physiological stimulation regulates the exocytic mode through calcium activation of protein kinase C in mouse chromaffin cells. Biochem. J., 399, 111 119.
21. Fulop, T., Radabaugh, S. Smith, C. (2005) Activity-dependent differential transmitter release in mouse adrenal chromaffin cells. J. Neurosci., 25, 7324 7332.
22. Gomez, J.F., Brioso, M.A., Machado, J.D., Sanchez, J.L. Borges, R. (2002) New approaches for analysis of amperometrical recordings. Ann. N Y Acad. Sci., 971, 647 654.
23. Graham, M.E. Burgoyne, R.D. (2000) Comparison of cysteine string protein (Csp) and mutant alpha-SNAP overexpression reveals a role for csp in late steps of membrane fusion in dense-core granule exocytosis in adrenal chromaffin cells. J. Neurosci., 20, 1281 1289.
24. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. Bird, A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322 326.
25. Hagberg, B., Aicardi, J., Dias, K. Ramos, O. (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol., 14, 471 479.
26. Hansen, O., Johansson, B.W. Nilsson-Ehle, P. (1990) Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade. Angiology, 41, 175 188.
27. Horrigan, F.T. Bookman, R.J. (1994) Releasable pools and the kinetics of exocytosis in adrenal chromaffin cells. Neuron, 13, 1119 1129.
28. Johansson, B.W., Hansen, O., Juul-Moller, S. Svensson, O. (1988) Adrenaline-induced changes in serum electrolytes, ECG, and blood pressure, with Ca-blockade pretreatment. Angiology, 39, 345 354.
29. Jordan, C., Li, H.H., Kwan, H.C. Francke, U. (2007) Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med. Genet., 8, 36.
30. Julu, P.O. Witt Engerstrom, I. (2005) Assessment of the maturity-related brainstem functions reveals the heterogeneous phenotypes and facilitates clinical management of Rett syndrome. Brain Dev., 27 (Suppl 1 S43 S53.
31. Julu, P.O., Kerr, A.M., Hansen, S., Apartopoulos, F. Jamal, G.A. (1997a) Functional evidence of brain stem immaturity in Rett syndrome. Eur. Child Adolesc. Psychiatry, 6 (Suppl 1 47 54.
32. Julu, P.O., Kerr, A.M., Hansen, S., Apartopoulos, F. Jamal, G.A. (1997b) Immaturity of medullary cardiorespiratory neurones leading to inappropriate autonomic reactions as a likely cause of sudden death in Rett's syndrome. Arch. Dis. Child., 77, 464 465.
33. Julu, P.O., Kerr, A.M., Apartopoulos, F., Al-Rawas, S., Engerstrom, I.W., Engerstrom, L., Jamal, G.A. Hansen, S. (2001) Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder. Arch. Dis. Child., 85, 29 37.
34. Keating, D.J., Dubach, D., Zanin, M.P., Yu, Y., Martin, K., Zhao, Y.F., Chen, C., Porta, S., Arbones, M.L., Mittaz, L. Pritchard, M.A. (2008) DSCR1/RCAN1 regulates vesicle exocytosis and fusion pore kinetics: implications for Down syndrome and Alzheimer's disease. Hum. Mol. Genet., 17, 1020 1030.
35. Kidokoro, Y. Ritchie, A.K. (1980) Chromaffin cell action potentials and their possible role in adrenaline secretion from rat adrenal medulla. J. Physiol., 307, 199 216.
36. Lekman, A., Witt-Engerstrom, I., Gottfries, J., Hagberg, B.A., Percy, A.K. Svennerholm, L. (1989) Rett syndrome: biogenic amines and metabolites in postmortem brain. Pediatr. Neurol., 5, 357 362.
37. Lekman, A., Witt-Engerstrom, I., Holmberg, B., Percy, A., Svennerholm, L. Hagberg, B. (1990) CSF and urine biogenic amine metabolites in Rett syndrome. Clin. Genet., 37, 173 178.
38. Malmejac, J. (1964) Activity of the adrenal medulla and its regulation. Physiol. Rev., 44, 186 218.
39. McGill, B.E., Bundle, S.F., Yaylaoglu, M.B., Carson, J.P., Thaller, C. Zoghbi, H.Y. (2006) Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl Acad. Sci. USA, 103, 18267 18272.
40. Moretti, P. Zoghbi, H.Y. (2006) MeCP2 dysfunction in Rett syndrome and related disorders. Curr. Opin. Genet. Dev., 16, 276 281.
41. Mullaney, B.C., Johnston, M.V. Blue, M.E. (2004) Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain. Neuroscience, 123, 939 949.
42. Naidu, S., Chatterjee, S., Murphy, M., Uematsu, S., Phillapart, M. Moser, H. (1987) Rett syndrome: new observations. Brain Dev., 9, 525 528.
43. Nishiyama, T. (2005) Hemodynamic and catecholamine response to a rapid increase in isoflurane or sevoflurane concentration during a maintenance phase of anesthesia in humans. J. Anesth., 19, 213 217.
44. Ogier, M. Katz, D.M. (2008) Breathing dysfunction in Rett syndrome: understanding epigenetic regulation of the respiratory network. Respir. Physiol. Neurobiol., 164, 55 63.
45. Ogier, M., Wang, H., Hong, E., Wang, Q., Greenberg, M.E. Katz, D.M. (2007) Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome. J. Neurosci., 27, 10912 10917.
46. Pelka, G.J., Watson, C.M., Radziewic, T., Hayward, M., Lahooti, H., Christodoulou, J. Tam, P.P. (2006) Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Brain, 129, 887 898.
47. Perez, F.A. Palmiter, R.D. (2005) Parkin-deficient mice are not a robust model of parkinsonism. Proc. Natl Acad. Sci. USA, 102, 2174 2179.
48. Perry, T.L., Dunn, H.G., Ho, H.H. Crichton, J.U. (1988) Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome. J. Pediatr., 112, 234 238.
49. Riederer, P., Brucke, T., Sofic, E., Kienzl, E., Schnecker, K., Schay, V., Kruzik, P., Killian, W. Rett, A. (1985) Neurochemical aspects of the Rett syndrome. Brain Dev., 7, 351 360.
50. Roux, J.C., Dura, E. Villard, L. (2008) Tyrosine hydroxylase deficit in the chemoafferent and the sympathoadrenergic pathways of the Mecp2 deficient mouse. Neurosci. Lett., 447, 82 86.
51. Saito, Y., Ito, M., Ozawa, Y., Matsuishi, T., Hamano, K. Takashima, S. (2001) Reduced expression of neuropeptides can be related to respiratory disturbances in Rett syndrome. Brain Dev., 23 (Suppl 1 S122 S126.
52. Samaco, R.C., Fryer, J.D., Ren, J., Fyffe, S., Chao, H.T., Sun, Y., Greer, J.J., Zoghbi, H.Y. Neul, J.L. (2008) A partial loss of function allele of methyl-CpG-binding protein 2 predicts a human neurodevelopmental syndrome. Hum. Mol. Genet., 17, 1718 1727.
53. Shahbazian, M.D. Zoghbi, H.Y. (2002) Rett syndrome and MeCP2: linking epigenetics and neuronal function. Am. J. Hum. Genet., 71, 1259 1272.
54. Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R. Zoghbi, H. (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron, 35, 243 254.
55. Smith, C., Moser, T., Xu, T. Neher, E. (1998) Cytosolic Ca2+ acts by two separate pathways to modulate the supply of release-competent vesicles in chromaffin cells. Neuron, 20, 1243 1253.
56. Sugita, S. (2008) Mechanisms of exocytosis. Acta Physiol. (Oxf.), 192, 185 193.
57. Van den Veyver, I.B. Zoghbi, H.Y. (2002) Genetic basis of Rett syndrome. Ment. Retard. Dev. Disabil. Res. Rev., 8, 82 86.
58. Voets, T., Neher, E. Moser, T. (1999) Mechanisms underlying phasic and sustained secretion in chromaffin cells from mouse adrenal slices. Neuron, 23, 607 615.
59. Vorsanova, S.G., Iourov, I.Y. Yurov, Y.B. (2004) Neurological, genetic and epigenetic features of Rett syndrome. J. Pediatr. Neurol., 2, 179 190.
60. Wang, H., Chan, S.A., Ogier, M., Hellard, D., Wang, Q., Smith, C. Katz, D.M. (2006) Dysregulation of brain-derived neurotrophic factor expression and neurosecretory function in Mecp2 null mice. J. Neurosci., 26, 10911 10915.
61. Weese-Mayer, D.E., Lieske, S.P., Boothby, C.M., Kenny, A.S., Bennett, H.L., Silvestri, J.M. Ramirez, J.M. (2006) Autonomic nervous system dysregulation: breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr. Res., 60, 443 449.
62. Zapanti, E. Ilias, I. (2006) Pheochromocytoma: physiopathologic implications and diagnostic evaluation. Ann. N Y Acad. Sci., 1088, 346 360.
63. Zoghbi, H.Y., Percy, A.K., Glaze, D.G., Butler, I.J. Riccardi, V.M. (1985) Reduction of biogenic amine levels in the Rett syndrome. N. Engl. J. Med., 313, 921 924.
64. Zoghbi, H.Y., Milstien, S., Butler, I.J., Smith, E.O., Kaufman, S., Glaze, D.G. Percy, A.K. (1989) Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann. Neurol., 25, 56 60.